Caltrate LAST VERIFIED: August 5, 2026

Caltrate is a bone-health supplement brand owned by the Haleon group of companies, focused on calcium and vitamin D3. The line covers 600+D3 tablets, soft chews, gummies, and minis, and the brand claims ‘the most vitamin D3 per tablet among leading calcium supplement brands.’ It is a genuinely global property, with more than 13 localized country domains, a dedicated quality page, and the standard FDA supplement disclaimers. The US site functions purely as an informational brand destination rather than a store, presenting the product range and educational content on calcium and bone health to shoppers researching before a retail purchase.

There are no commercial terms to evaluate because the site transacts nothing. No MOQ, minimum order value, shipping terms, or payment methods are published; instead, buyers are routed to a ‘Find a Store’ locator and to coupons via the Haleon myHealth program. No account is required, and none can be created for purchasing purposes. Supplier, wholesale, and distributor information is entirely absent — this domain exists to support retail sell-through of Caltrate products stocked by mass-market pharmacies and grocers, not to originate orders of any kind, whether consumer or trade.

The record’s red flag is exactly this: no e-commerce, pricing, or supplier/wholesale information anywhere on the site. Caltrate suits shoppers researching bone-health products before buying at retail, and the Haleon parentage gives the brand mainstream credibility. Retailers wanting to stock Caltrate must source through Haleon’s trade channels or established distributors, since this domain offers no path to a direct account. The vitamin D3 superiority positioning is a company claim, not independently verified here. As a supplier listing, this is a brand reference point only — useful for assortment planning, of no use for direct procurement.